United States: Treatment Of Antibody Claims In The U.S. After Amgen v. Sanofi - Harness IP

Credit: Mondaq- Published on February 19, 2024

The future of antibody claiming in the United States is uncertain following the U.S. Supreme Court's May 2023 ruling in Amgen Inc. v. Sanofi, 598 U.S. 594 (2023), a highly anticipated decision...

👓 View full article:

You are here

› Legal › United States: Treatment Of Antibody Claims In The U.S. After Amgen v. Sanofi - Harness IP

Related videos from verified sources

Z!NC !0N0PH0RE$ / GEN0T0X!C!TY / !ATRAGEN!C!TY / PLACEB0 / N0CEB0 00:21

Credit: Rumble - Published on February 24, 2024

Biden Calls Putin a ‘Crazy SOB’ 01:31

Credit: Wibbitz Top Stories - Published on February 22, 2024

Political Differences Driving US Migration Habits 01:31

Credit: Wibbitz Top Stories - Published on February 22, 2024

You might like